Inbrija (Formerly often known as CVT-301) can be an inhaled powder formulation of levodopa indicated for the intermittent therapy of "off episodes" in clients with Parkinson's sickness currently having carbidopa/levodopa. Also, L-DOPA supplements have not been authorised through the